Table II.
Demographic data according to type of used cardioplegic solution
| Parameter | FR | ST | BL |
|---|---|---|---|
| Demographic variables: | |||
| N | 432 | 440 | 257 |
| Gender (female/male) | 204/228 | 207/233 | 103/154 |
| Age [days] | 295 (77–741) | 313 (82–967) | 366 (116–999) |
| Body weight [kg] | 7.2 (4.1–11.5) | 7.5 (4.1–13) | 8.6 (4.9–13.5) |
| Body surface area [m2] | 0.37 (0.25–0.52) | 0.38 (0.24–0.57) | 0.41 (0.28–0.59) |
| Down’s syndrome | 53 | 49 | 31 |
| Intraoperative variables: | |||
| CBP [min] | 83 (52–123) | 89 (60–126) | 81 (50–118) |
| Ao-x-clamp [min] | 42 (24–66) | 45 (27–62) | 43 (24–61) |
| Postoperative variables: | |||
| ICU time [days] | 4 (3–9) | 4 (3–8) | 4 (3–8) |
| Mechanical ventilation [h] | 18 (7–73) | 22 (8–75) | 12 (7–39) |
| 30-day mortality (%) | 14.9 | 14.9 | 8.9 |
FR – Fresenius crystalloid cardioplegic solution, ST – St. Thomas crystalloid cardioplegic solution, BL – Calafiore cold blood cardioplegic solution, CBP – cardiopulmonary bypass time, Ao-x-clamp – aortic cross-clamp time, ICU time – intensive care unit stay time. Data presented as median and ranges.